George Yancopoulos
Known title: President and Chief ScientificCIK: 0001226690
Associated companies
Transaction History
| REGN | ▼ Sell | Tax Withholding | 28,570 | $22.1M | 12/31/2025 | View on chart |
| REGN | ▲ Buy | Option Exercise | 28,570 | $0 | 12/31/2025 | View on chart |
| REGN | ▲ Buy | Option Exercise | 146,815 | $81.6M | 12/9/2025 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 131,874 | $92.5M | 12/9/2025 | View on chart |
| REGN | ▼ Sell | Gift | 75,799 | $0 | 6/10/2024 | View on chart |
| REGN | ▼ Sell | Gift | 37,900 | $0 | 6/10/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 3,213 | $3.1M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 9,501 | $9.2M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 790 | $768K | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 7,611 | $7.4M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 9,242 | $9.0M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 4,886 | $4.8M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,227 | $1.2M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 2,653 | $2.6M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 4,922 | $4.8M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 4,669 | $4.5M | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 379 | $371K | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 907 | $877K | 5/16/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 182 | $180K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 373 | $369K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 120 | $119K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,428 | $1.4M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 3,387 | $3.3M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,930 | $1.9M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 406 | $394K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 111 | $107K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 846 | $821K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 782 | $756K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 784 | $762K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,865 | $1.8M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 4,778 | $4.7M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 5,225 | $5.1M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 6,885 | $6.7M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 9,851 | $9.6M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 4,865 | $4.8M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 504 | $494K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 1,223 | $1.2M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 2,283 | $2.2M | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 303 | $298K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 727 | $715K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 53 | $52K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 647 | $638K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 442 | $436K | 5/15/2024 | View on chart |
| REGN | ▼ Sell | Gift | 18,148 | $0 | 4/29/2024 | View on chart |
| REGN | ▼ Sell | Gift | 36,296 | $0 | 4/29/2024 | View on chart |
| REGN | ▲ Buy | Option Exercise | 172,723 | $69.0M | 2/15/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 123,601 | $117.9M | 2/15/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 16,848 | $15.2M | 1/2/2024 | View on chart |
| REGN | ▼ Sell | Open Market | 16,848 | $15.2M | 1/2/2024 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 12,841 | $10.8M | 12/11/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 25,155 | — | 12/11/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 1,237 | $993K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 642 | $516K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 254 | $204K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 254 | $203K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 122 | $98K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 47 | $38K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 700 | $565K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 400 | $324K | 3/23/2023 | View on chart |
| REGN | ▼ Sell | Open Market | 13,189 | $10.6M | 2/6/2023 | View on chart |
| REGN | ▲ Buy | Option Exercise | 239,063 | $42.8M | 12/22/2021 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 159,915 | $97.6M | 12/22/2021 | View on chart |
| REGN | ▲ Buy | Option Exercise | 203,204 | $55.0M | 12/22/2021 | View on chart |
| REGN | ▼ Sell | Tax Withholding | 150,182 | $91.6M | 12/22/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 46,925 | $29.3M | 8/16/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 2,302 | $1.4M | 8/16/2021 | View on chart |
| REGN | ▼ Sell | Open Market | 773 | $483K | 8/13/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock
Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.
Regeneron Gets EU Approval for Libtayo Dosing, UBS Upgrades Stock. Regeneron received a positive recommendation from the EU's CHMP for an updated Libtayo dosing regimen across all approved cancer types. This regulatory progress follows strong earnings and new Phase III data for a treatment for FOP. UBS recently upgraded the stock to Buy and raised its price target to $978, citing the company's potential value.